Filing Flows › Novartis AG (NVS) › Q2 2026 › vs Q2 2025
Novartis AG (NVS) Q2 2026 vs Q2 2025 (year over year)
Novartis AG's revenue rose $354M (+3%) from $14.1B in Q2 2025 to $14.4B in Q2 2026. Operating margin 33.0% against 34.6% (-1.6 pts).
Novartis AG, Q2 2026: revenue $14.4B (+2% year over year), operating margin 33.0%, net earnings $3.3B, operating cash flow $5.9B. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 33.0% | 34.6% | -1.6 pts |
| Net margin | 22.6% | 28.6% | -6.0 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $14.4B | $14.1B | $354M | +3% |
| Operating profit | $4.8B | $4.9B | −$114M | -2% |
| Costs & expenses | $9.7B | $9.2B | $468M | +5% |
| Pre-tax earnings | $3.3B | $4.0B | −$767M | -19% |
| Other expense, net | $1.5B | $840M | $653M | +78% |
| Net earnings | $3.3B | $4.0B | −$767M | -19% |
| Working capital & other | $2.6B | $2.6B | −$15.0M | -0.6% |
| Operating cash flow | $5.9B | $6.7B | −$782M | -12% |
Questions
How much did Novartis AG's revenue grow year over year in Q2 2026?
Novartis AG's revenue rose $354M (+3%) from $14.1B in Q2 2025 to $14.4B in Q2 2026. Operating margin 33.0% against 34.6% (-1.6 pts).